Related Experiment Video
Updated: Jun 2, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Toxin models of mitochondrial dysfunction in Parkinson's disease
Terina N Martinez1, J Timothy Greenamyre
1Pittsburgh Institute for Neurodegenerative Diseases, Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Antioxidants & Redox Signaling
|May 11, 2011
Summary
Toxin models reveal mitochondrial dysfunction in Parkinson's disease (PD) pathogenesis. Further research is needed to bridge the gap between animal models and effective human therapeutics for PD.
Area of Science:
- Neuroscience
- Toxicology
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) involves progressive loss of dopaminergic neurons and dopamine deficiency.
- Mitochondrial dysfunction is an early factor in both familial and idiopathic PD.
- Toxin-induced animal models are crucial for studying parkinsonism.
Purpose of the Study:
- To review toxin models of mitochondrial dysfunction in experimental Parkinson's disease.
- To discuss mechanisms of mitochondrial neurotoxicity in PD.
- To highlight the importance of extranigral aspects in PD pathology.
Main Methods:
- Overview of toxin models, including novel methods like intranasal toxin exposure.
- Examination of mitochondrial mechanisms contributing to neurotoxicity.
- Analysis of epidemiological and molecular studies in human and animal models.
Main Results:
- Mitochondrial dysfunction is implicated early in PD pathogenesis.
- Toxin models offer insights into PD mechanisms, but none fully replicate human PD.
- Emerging research emphasizes extranigral pathology in parkinsonism.
Conclusions:
- Toxin models are valuable for understanding PD, but limitations exist.
- Optimizing existing and developing new animal models is essential.
- Translating findings from animal models to human therapeutics remains a challenge.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...